Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis. (16th April 2021)

• Record Type: Journal Article
• Authors: Huang, Zifeng; Si, Wenwen; Li, Xinrong; Ye, Shanyu; Liu, Xuelei; Ji, Yichun; Hao, Xiaoqian; Chen, Dongfeng; Zhu, Meiling
• Other Names: Fattahi Mohammad Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2021(2021)
• Publication Date: 2021-04-16
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2021/6668249
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Ferroptosis is associated with neural degeneration of dopaminergic neurons in Parkinson's disease (PD). However, how to control the level of ferroptosis in PD remains unclear. Clinically, moxibustion has been used to treat PD and has an apparent therapeutic effect on improving the motor symptoms of PD. In the present study, the PD rat model was constructed by two-point stereotactic 6-hydroxydopamine injection. Then, moxibustion was used to treat the PD rats. The expression of glutathione peroxidase 4 (GPX4) and Ferritin Heavy Chain 1 (FTH1), the level of reactive oxygen species (ROS), and the morphology of mitochondrial were detected to evaluate the level of ferroptosis. The results showed that moxibustion treatment of Shi's moxa sticks could reduce the behavioral score, alleviate the level of ferroptosis, decrease mitochondrial damage, and improve dopaminergic neuron survival. In conclusion, the present study results indicated that Shi's moxa sticks could effectively suppress the level of ferroptosis, thereby improving the survival of dopaminergic neurons in the SNpc of PD rats, which may provide a promising complementary and alternative therapy for PD patients.